Document Detail


The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity.
MedLine Citation:
PMID:  16267598     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study is to determine whether treatment increases the levels of anti-Proteus antibodies (APA) in patients with rheumatoid arthritis (RA). The blood samples of 32 patients suffering from RA who were recruited in our previous study and continued to participate in our follow-up study were collected after 1 year. Their first and follow-up samples were analysed for the presence of IgG isotype and total immunoglobulins (IgG+IgA+IgM) against Proteus mirabalis (PM) using enzyme-linked immunosorbent assay with two kinds of antigen preparations: whole bacteria and sodium dodecyl sulphate (SDS) lysed bacterial extract. All patients were treated with methotrexate and hydroxychloroquine with adequate dose of non-steroidal anti-inflammatory drug. After 1 year, 11 patients were in clinical remission [erythrocyte sedimentation rate (ESR) less than 30 mm/h and C-reactive protein (CRP) less than or equal to 10 mg/l], while the rest of the 21 were in the state of active disease. Correlation and Student's t test were used for statistical analysis. APA titres were significantly elevated in patients after 1 year of therapy. However, the rise was not different between patients who were in clinical remission and those in the state of active disease. APA titre increases in the treatment of RA, and the probable mechanisms are discussed.
Authors:
S Chandrashekara; Rajreddy Patil; H S Vadiraja; A Shobha
Related Documents :
12649398 - Elevated levels of synovial fluid antibodies reactive with the small proteoglycans bigl...
16052578 - Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated...
12890858 - Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxid...
8356248 - What is the natural history of rheumatoid arthritis?
9186248 - Persistence of photosensitivity.
15978938 - Aberrant dna methylation of a cell cycle regulatory pathway composed of p73, p15 and p5...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2005-11-03
Journal Detail:
Title:  Clinical rheumatology     Volume:  25     ISSN:  0770-3198     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-07-27     Completed Date:  2006-11-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  520-3     Citation Subset:  IM    
Affiliation:
Department of Clinical Immunology, M.S Ramaiah Medical College, 560054, Bangalore, India. chandrashekara_s@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Bacterial / blood*
Antibody Specificity
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications*,  drug therapy
Female
Folic Acid / therapeutic use
Follow-Up Studies
Humans
Hydroxychloroquine / therapeutic use
Immunoglobulins / blood
Male
Methotrexate / therapeutic use
Middle Aged
Proteus Infections / blood,  complications*,  immunology
Proteus mirabilis / immunology
Remission Induction
Serologic Tests
Steroids / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Antibodies, Bacterial; 0/Antirheumatic Agents; 0/Immunoglobulins; 0/Steroids; 118-42-3/Hydroxychloroquine; 59-05-2/Methotrexate; 59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exceptionally slow kinetics of the intramolecular quadruplex formed by the Oxytricha telomeric repea...
Next Document:  Cutaneous lesions as presenting symptoms of primary biliary cirrhosis: an undifferentiated connectiv...